Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Continuous Glucose Monitoring Set to Emerge as Key Diabetes Management Tool; Greystone Associates Sees Rapid Adoption of Improved Devices.


AMHERST, N.H. -- After more than a decade of hopeful anticipation, the wait for a better way to manage blood glucose levels blood glucose level,
n level of glu-cose in the bloodstream, normally about 70 to 115 mg/dL after fasting overnight. Higher levels may indicate diseases such as diabetes mellitus.
 appears to finally be over for diabetes patients. Advances in sensing and signal processing See DSP.  are enabling new and innovative monitor designs that allow patients to check glucose readings as often as once every minute without having to prick a finger. By employing wireless technology to transmit readings to a small LED display, patients are free of the wires that typified earlier designs.

Four continuous monitors are already FDA-approved, and several others are winding their way through the clinical trial process. All are competing for a share of a $5 billion world market for glucose monitoring glucose monitoring Lab medicine The periodic evaluation of any analyte abnormal in Pts with DM, to assess short and long-term control with antiglycemic agents. See Glucose, Glycated hemoglobin. , a market that is expected to grow at a significant rate for the rest of the decade.

"The self-testing market for blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence  will continue to expand due to several factors," explains George Perros, Greystone Associates Managing Director. "The aging of the population in most developed countries, new criteria for the diagnosis of diabetes that emphasizes lower glucose thresholds, and expansion of monitoring technologies into emerging market populations will all contribute to a growing market."

These findings are contained in a new and comprehensive report. Continuous Glucose Monitors: Technology, Players and Prospects examines the devices, companies, and technology that are changing the way diabetes is managed.

More information on this report is available at www.greystoneassociates.org.

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee
consulting company

business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a
 providing services in strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. , venture development, product commercialization, and technology and market assessment.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Apr 10, 2006
Words:260
Previous Article:Techedge Inc. Signs Definitive Agreement to Acquire China BioPharma Ltd.
Next Article:Scott Franklin of the Motion Picture Group, Inc. Directs Daddy Yankee Music Video for Interscope Records.
Topics:



Related Articles
FDA OKS MINIMED DEVICE FOR DIABETICS.
MINIMED SHARES UP 10 PERCENT; HEARING DATE SET FOR DIABETES DEVICE.
Emerging technology in diabetes mellitus: glucose monitoring and new insulins. (Review Article).
Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach.
Strategies for insulin therapy in type 2 diabetes.
Medtronic Receives FDA Approval for World's First Insulin Pump with Real-Time Continuous Glucose Monitoring.
Perioperative glucose control in the diabetic or nondiabetic patient.
Medtronic Receives FDA Approval for Guardian(R) REAL-Time Continuous Glucose Monitoring System; System Provides Patients Superior Protection than...
Why and how to use insulin therapy earlier in the management of type 2 diabetes.
Management of diabetes-related hypoglycemia.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles